PURPOSE: In hematopoietic stem cell transplantation (HSCT), cyclosporin is used to prevent graft-versus-host disease (GVHD). However, cyclosporin distribution in tissues is not linear, resulting in uncertainty regarding optimal dosing and monitoring. The objective of this study was to link the probability and severity of acute GVHD to cyclosporin exposure in blood, GVHD target organs, and lymphoid organs. METHODS: A physiologically based pharmacokinetic model of cyclosporin disposition and logistic regression models were used. Sixty-one pediatric patients undergoing HSCT were studied. Cyclosporin was administered by intermittent (n = 31) or continuous infusion (n = 30). RESULTS: At steady state (1 day before acute GVHD), exposures in all organs were related with the probability and severity of acute GVHD. Average cyclosporin concentration or, equivalently, its area under the curve (AUC) was the pharmacokinetic index best correlated with the anti-GVHD effect. Cyclosporin AUC in interstitial fluid of lymphoid organs was a superior index than that in blood, but marginally. CONCLUSION: Hence, AUC in blood maybe used as an index of cyclosporin efficacy. Using our model, target AUCs in blood could be defined for malignant and non-malignant diseases, as well as the equivalent target values for C(2) and C(0) concentrations.
PURPOSE: In hematopoietic stem cell transplantation (HSCT), cyclosporin is used to prevent graft-versus-host disease (GVHD). However, cyclosporin distribution in tissues is not linear, resulting in uncertainty regarding optimal dosing and monitoring. The objective of this study was to link the probability and severity of acute GVHD to cyclosporin exposure in blood, GVHD target organs, and lymphoid organs. METHODS: A physiologically based pharmacokinetic model of cyclosporin disposition and logistic regression models were used. Sixty-one pediatric patients undergoing HSCT were studied. Cyclosporin was administered by intermittent (n = 31) or continuous infusion (n = 30). RESULTS: At steady state (1 day before acute GVHD), exposures in all organs were related with the probability and severity of acute GVHD. Average cyclosporin concentration or, equivalently, its area under the curve (AUC) was the pharmacokinetic index best correlated with the anti-GVHD effect. Cyclosporin AUC in interstitial fluid of lymphoid organs was a superior index than that in blood, but marginally. CONCLUSION: Hence, AUC in blood maybe used as an index of cyclosporin efficacy. Using our model, target AUCs in blood could be defined for malignant and non-malignant diseases, as well as the equivalent target values for C(2) and C(0) concentrations.
Authors: Alida L P Caforio; Francesco Tona; Stefano Piaserico; Antonio Gambino; Giuseppe Feltrin; Anna Belloni Fortina; Annalisa Angelini; Mauro Alaibac; Martina Bontorin; Diego Calzolari; Andrea Peserico; Gaetano Thiene; Sabino Iliceto; Gino Gerosa Journal: Transpl Int Date: 2005-01 Impact factor: 3.782
Authors: J Li; Uta Dahmen; S Beckebaum; V Cicinnati; C Valentin-Gamazo; A Frilling; M Malago; C E Broelsch Journal: Eur J Med Res Date: 2006-04-28 Impact factor: 2.175
Authors: H Glucksberg; R Storb; A Fefer; C D Buckner; P E Neiman; R A Clift; K G Lerner; E D Thomas Journal: Transplantation Date: 1974-10 Impact factor: 4.939
Authors: M P Hendriks; N M A Blijlevens; A V M B Schattenberg; D M Burger; J P Donnelly Journal: Bone Marrow Transplant Date: 2006-10 Impact factor: 5.483
Authors: N Ogawa; Y Kanda; M Matsubara; Y Asano; M Nakagawa; M Sakata-Yanagimoto; K Kandabashi; K Izutsu; Y Imai; A Hangaishi; M Kurokawa; S Tsujino; S Ogawa; K Aoki; S Chiba; T Motokura; H Hirai Journal: Bone Marrow Transplant Date: 2004-03 Impact factor: 5.483
Authors: P Martin; N Bleyzac; G Souillet; C Galambrun; Y Bertrand; P H Maire; R W Jelliffe; G Aulagner Journal: Bone Marrow Transplant Date: 2003-10 Impact factor: 5.483
Authors: N Bleyzac; D Cuzzubbo; C Rénard; N Garnier; V Dubois; C Domenech; M-P Goutagny; A Plesa; N Grardel; S Goutelle; A Janoly-Duménil; Y Bertrand Journal: Bone Marrow Transplant Date: 2016-01-25 Impact factor: 5.483